Relevant bibliographies by topics / Slow Vital Capacity

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters
  4. Conference papers
  5. Reports

Academic literature on the topic 'Slow Vital Capacity'

Author: Grafiati
Published: 3 June 2025
Last updated: 22 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Slow Vital Capacity.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Slow Vital Capacity"

1

Singh, Shruti, Sara Z. Khan, Bhakti Patel, Rammohan Gumpeni, Sameer Verma, and Arunabh Talwar. "Slow vital capacity." International Journal of Advances in Medicine 8, no. 1 (2020): 144. http://dx.doi.org/10.18203/2349-3933.ijam20205488.

Full text
Abstract:
Forced vital capacity (FVC) and slow vital capacity (SVC) are non-invasive tests of respiratory function. Although FVC has been extensively studied and is used in most PFT (pulmonary function test) labs, SVC can also be used in clinical practice as it is a more comfortable and convenient test to perform. SVC-based diagnostic criteria can lead to earlier detection of obstructive lung disease. In contrast to FVC, SVC is less affected by respiratory muscle fatigue, airflow patency, expiratory muscle weakness and air leakage making it an appropriate test of respiratory function in patients of amyotrophic lateral sclerosis (ALS) and other neuromuscular disorders. As respiratory insufficiency is the major cause of mortality in ALS patients, regular SVC measurement provides the respiratory functional status, so that early treatment can be started which improves the survival and quality of life in these patients. The purpose of this article is to highlight the importance of considering SVC in clinical practice.
APA, Harvard, Vancouver, ISO, and other styles
2

Chhabra, S. K. "Forced Vital Capacity, Slow Vital Capacity, or Inspiratory Vital Capacity: Which Is the Best Measure of Vital Capacity?" Journal of Asthma 35, no. 4 (1998): 361–65. http://dx.doi.org/10.3109/02770909809075669.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alberto de Castro Pereira, Carlos. "Difference between slow vital capacity and forced vital capacity in the diagnosis of airflow limitation." Jornal Brasileiro de Pneumologia 46, no. 2 (2020): e20200060-e20200060. http://dx.doi.org/10.36416/1806-3756/e20200060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cohen, Judith, Dirkje S. Postma, Karin Vink-Klooster, et al. "FVC to Slow Inspiratory Vital Capacity Ratio." Chest 132, no. 4 (2007): 1198–203. http://dx.doi.org/10.1378/chest.06-2763.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Huprikar, Nikhil, Valerie Bedsole, Tyson Sjulin, Michael Morris, and Andrew Skabelund. "An Evaluation of Slow Vital Capacity and Forced Vital Capacity Difference in Referred Patient Cohort." Chest 152, no. 4 (2017): A955. http://dx.doi.org/10.1016/j.chest.2017.08.990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kang, Tae-Wook, and Jae-Seok Lee. "Effect of the Diaphragm Release Technique for a Diaphragmatic Mobility and Slow Vital Capacity." KOREAN ACADEMY OF CARDIORESPIRATORY PHYSICAL THERAPY 11, no. 2 (2023): 21–26. http://dx.doi.org/10.32337/kacpt.2023.11.2.21.

Full text
Abstract:
Purpose: The purpose of this study was to investigate the immediate effect of diaphragm release technique applied to healthy adults on diaphragmatic mobility and slow vital capacity.
 Methods: This study included 21 healthy participants (13 males and 8 females). The participants performed exercises 10 times in 1 set diaphragm release technique, with a total of 3 sets. Before and after the intervention of the diaphragm release technique, diaphragmatic mobility was assessed using ultrasound, and slow vital capacity was evaluated using a portable digital spirometry device.
 Results: After the diaphragm release technique intervention, diaphragmatic mobility significantly increased in quiet breathing and deep breathing. In the case of slow vital capacity, only vital capacity increased significantly.
 Conclusion: Diaphragmatic mobility and slow vital capacity were affected by the diaphragm release technique, and it is believed that the diaphragm release technique will be useful as an intervention method in order to improve respiratory function.
APA, Harvard, Vancouver, ISO, and other styles
7

Han, Dongwook, Nayoon Yoon, Yeongran Jeong, Misook Ha, and Kunwoo Nam. "Effects of cervical self-stretching on slow vital capacity." Journal of Physical Therapy Science 27, no. 7 (2015): 2361–63. http://dx.doi.org/10.1589/jpts.27.2361.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lee, Juncheol, Sehee Hwang, Seungim Han, and Dongwook Han. "Effects of stretching the scalene muscles on slow vital capacity." Journal of Physical Therapy Science 28, no. 6 (2016): 1825–28. http://dx.doi.org/10.1589/jpts.28.1825.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nortje, Andre. "The Value of the Slow Vital Capacity in Diagnosing COPD." African Journal of Thoracic and Critical Care Medicine 27, no. 3 (2021): 127. http://dx.doi.org/10.7196/ajtccm.2021.v27i3.165.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Calvo, Andrea, Rosario Vasta, Cristina Moglia, et al. "Prognostic role of slow vital capacity in amyotrophic lateral sclerosis." Journal of Neurology 267, no. 6 (2020): 1615–21. http://dx.doi.org/10.1007/s00415-020-09751-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Slow Vital Capacity"

1

Andrews, Jinsy A., Lisa Meng, Sarah F. Kulke, et al. "Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis." AMER MEDICAL ASSOC, 2018. http://hdl.handle.net/10150/626557.

Full text
Abstract:
IMPORTANCE The prognostic value of slow vital capacity (SVC) in relation to respiratory function decline and disease progression in patients with amyotrophic lateral sclerosis (ALS) is not well understood. OBJECTIVE To investigate the rate of decline in percentage predicted SVC and its association with respiratory-related clinical events and mortality in patients with ALS. DESIGN, SETTING, AND PARTICIPANTS This retrospective study included 893 placebo-treated patients from 2 large clinical trials (EMPOWER and BENEFIT-ALS, conducted from March 28, 2011, to November 1, 2012, and from October 23, 2012, to March 21, 2014, respectively) and an ALS trial database (PRO-ACT, containing studies completed between 1990 and 2010) to investigate the rate of decline in SVC. Data from the EMPOWER trial (which enrolled adults with possible, probable, or definite ALS; symptom onset within 24 months before screening; and upright SVC at least 65% of predicted value for age, height, and sex) were used to assess the relationship of SVC to respiratory-related clinical events; 456 patients randomized to placebo were used in this analysis. The 2 clinical trials included patients from North America, Australia, and Europe. MAIN OUTCOMES AND MEASURES Clinical events included the earlier of time to death or time to decline in the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) respiratory subdomain, time to onset of respiratory insufficiency, time to tracheostomy, and all-cause mortality. RESULTS Among 893 placebo-treated patients with ALS, the mean (SD) patient age was 56.7 (11.2) years, and the mean (SD) SVC was 90.5%(17.1%) at baseline; 65.5%(585 of 893) were male, and 20.5%(183 of 893) had bulbar-onset ALS. In EMPOWER, average decline of SVC from baseline through 1.5-year follow-up was - 2.7 percentage points per month. Steeper declines were found in patients older than 65 years (-3.6 percentage points per month [P=.005 vs < 50 years and P=.007 vs 50-65 years) and in patients with an ALSFRS-R total score of 39 or less at baseline (-3.1 percentage points per month [P<.001 vs >39]). When the rate of decline of SVC was slower by 1.5 percentage points per month in the first 6 months, risk reductions for events after 6 months were 19% for decline in the ALSFRS-R respiratory subdomain or death after 6 months, 22% for first onset of respiratory insufficiency or death after 6 months, 23% for first occurrence of tracheostomy or death after 6 months, and 23% for death at any time after 6 months (P<.001 for all). CONCLUSIONS AND RELEVANCE The rate of decline in SVC is associated with meaningful clinical events in ALS, including respiratory failure, tracheostomy, or death, suggesting that it is an important indicator of clinical progression.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Slow Vital Capacity"

1

Kemeni Kambiet, Perez L., and Marcellus Forh Mbah. "Climate Change Education in African Higher Education Institutions: Insights into Current Practices and Future Directions." In Practices, Perceptions and Prospects for Climate Change Education in Africa. Springer Nature Switzerland, 2025. https://doi.org/10.1007/978-3-031-84081-4_17.

Full text
Abstract:
Abstract Climate change education (CCE) is a vital tool for addressing Africa’s vulnerability to climate change and advancing sustainable development. Its impact is even more significant when integrated into higher educational systems. Notably, Higher Education serves as a catalyst for innovation and nation-building and, hence, an essential medium for driving sustainability efforts across present and future generations. However, evidence suggests that the adoption of CCE in African Higher Education Institutions (HEIs) remains low. Few HEIs have specialized courses on the subject, while others have an integrated approach within related subjects like geography and environmental sciences. This underscores the necessity to identify the factors behind the slow uptake of CCE across the continent. Given this premise, our study seeks to explore the nature of the barriers as well as existing and future opportunities for scaling up climate change education in African HEIs. Among other factors, we identified resource limitations, institutional barriers, and socio-political challenges as the primary constraints to CCE uptake in Africa. On the other hand, the increasing climate commitment and the development of regional climate institutions equally provide a unique opportunity for capacity building, knowledge exchange and the spread of CCE across African HEI. Moreover, the rapid development of affordable digital communication and computing has the potential to increase networking and collaborative efforts between climate change learners and scientists across the region. These prospects signal a need for regional governments to multiply their efforts towards providing an environment for the development and uptake of suitable CCE programs.
APA, Harvard, Vancouver, ISO, and other styles
2

Ahmed, Muhammad Fayyaz, and Furqan Ahmed. "Lung Volumes and Capacity." In Basic Anesthesia Review, edited by Alaa Abd-Elsayed. Oxford University PressNew York, 2024. http://dx.doi.org/10.1093/med/9780197584569.003.0211.

Full text
Abstract:
Abstract Lung volumes are vital parameters in clinical medicine, and changes in lung volumes can give useful information about lung function. Lung volumes are measured with a spirometer. Lung capacities are a sum of two or more lung volumes. Furthermore, lung volumes are classified into dynamic and static lung volumes, depending on how the breaths are measured in a spirometer. Slow breaths measure static lung volumes, whereas fast breaths measure dynamic lung volumes . Static lung volumes are residual volume, expiratory reserve volume, inspiratory reserve volume, inspiratory capacity, tidal volume, vital capacity, forced residual capacity, and total lung capacity. Dynamic lung volumes are forced expiratory volume in one second and forced vital capacity.
APA, Harvard, Vancouver, ISO, and other styles
3

Rao A, Dr Babitha. "OUTSIDE FOOD AND AYURVEDA." In Futuristic Trends in Medical Sciences Volume 3 Book 16. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3bdms16p1ch4.

Full text
Abstract:
Food is one of the 3 pillars of Ayurveda as being the base of health; it's always suggested to eat well unctuous freshly cooked easily digestible food. Considering all this home food is always superior and best, though how much ever loyally followed sometimes outside food is unavoidable. So here the motto is to incorporate healthy food as much as possible. So outside food when and how?! The rationale is better than being hungry. Must to consider one's agni (metabolic capacity). prakruthi (Self constitution), desha(place) etc. Minimum criteria to follow are fresh, hygienic, warm, unctuous, healthy, likeable, must eat with whole mind on food neither too slow or fast.If aided with mantra(empowering), daana (feeding the animals, dependents etc) etc more beneficial. Never to be prescribed by peer, marketing etc. Water being vital part of food, locally available clean and warm water preferable. Food is part of daily routine, which adds on to long term health. Even WHO golden rules for safe food as almost included the above criteria. Let's start living and being healthy for achievement of dharma, artha, kaama, moksha as health is base for all this.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Slow Vital Capacity"

1

Barros, Raquel, Liliana Raposo, Nuno Moreira, et al. "Slow vital capacity : differences between expiratory and inspiratory vital capacities." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa3912.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nesterovska, Olga, Ganna Stupnytska, and Anastasiya Stupnytska. "Evaluation of Slow Vital capacity and Forced Vital Capacity in patients with COPD." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa748.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nesterovska, Olga, Ganna Stupnytska, Oleksandr Fediv, Oksana Pritulyak, and Iryna Nemish. "An Evaluation of Slow Vital Capacity and Forced Vital Capacity Difference in Aco Patients with Obesity." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.3077.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Warwick-Sanders, Michael, Will Backen, Cath Charlton, and Stephen C. Allen. "Slow (Relaxed) Vital Capacity Is Not A Useful Substitute For Forced Vital Capacity In Elderly Patients With Cognitive Impairment." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5977.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Junior, Marco, Emilia Costa, Flávio Andrade, et al. "Reliability of phonation maximum time and capacity in slow vital healthy subjects." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa4200.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rodríguez Moncalvo, Juan José, José Malet Ruiz, Marcelo Mastroianni, Marina Khoury, and Fabian Caro. "Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity?" In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4703.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Junior, Marco, Anna Escossio, Flávio Andrade, et al. "Validity and repeatability of the counting numbers technique from the slow vital capacity in hospitalized individuals." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa971.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rosas, M., A. P. Polito, and M. J. Morris. "Comparison of Forced and Slow Vital Capacity Maneuvers and Small Airway Indices in Patients Admitted for COPD Exacerbation." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4561.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lam, Jenny, Grace Pettigrew, Adelaide Withers, et al. "Feasibility and Inter-Test Reproducibility of Lung Clearance Index and Slow Vital Capacity in Children with Neuromuscular Disorders." In ERS Congress 2024 abstracts. European Respiratory Society, 2024. http://dx.doi.org/10.1183/13993003.congress-2024.pa1351.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jorge, Frederico Mennucci de Haidar, Angela Genge, Ammar Al Chalabi, et al. "MERIDIAN: A phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of pegcetacoplan in patients with amyotrophic lateral sclerosis." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.744.

Full text
Abstract:
Introduction: Inflammation underlies the pathogenesis of numerous neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). In ALS, the complement system has been implicated in the neuropathology of disease and disease progression. Pegcetacoplan, a subcutaneously administered C3 complement inhibitor, is being investigated in hematology, nephrology, and neurology. The current clinical study (NCT04579666) is investigating whether pegcetacoplan can improve survival and function in people diagnosed with apparent sporadic ALS. Objectives and Methodology: Evaluate the efficacy and safety of pegcetacoplan compared to placebo among people diagnosed with ALS in a global, multicenter, randomized, double-blind, placebo-controlled, phase 2 study. Approximately 228 patients diagnosed with apparent sporadic ALS, ≥18 years of age and with an ALS Functional Rating Scale-Revised (ALSFRS-R) score ≥30, slow vital capacity (SVC) ≥60% of the predicted value at screening, and with symptom onset within 72 weeks before screening, are eligible for enrollment. After screening, patients will be randomized 2:1 to treatment groups receiving either subcutaneous pegcetacoplan (1080 mg) or placebo twice weekly for a duration of 52 weeks. The primary efficacy endpoint is the difference in the Combined Assessment of Function and Survival (CAFS) ranked score at 52 weeks after treatment initiation. Additional, secondary functional efficacy (ALSFRS-R, percent SVC, muscle strength, quality of life, and caregiver burden) and safety endpoints will be analyzed at 52 weeks. After the placebo-controlled period, all patients will have the option to receive pegcetacoplan in an open-label period for an additional 52 weeks. Results: This ongoing study is currently enrolling participants. Conclusions: Results of this study will determine the role of complement and C3 inhibition in patients with ALS.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Slow Vital Capacity"

1

Corrales, Maria Elena, and Lourdes Alvarez. IDB-9: Evaluation of IDB-9 Commitments for Haiti. Inter-American Development Bank, 2013. http://dx.doi.org/10.18235/0010521.

Full text
Abstract:
The objective of this report is to assess the full and effective implementation of the Bank's support to Haiti in the wake of the 2010 earthquake, in fulfillment of the mandates of IDB-9, which included full debt forgiveness, delivery of concessional resources in 2010, and expansion of the Bank's Grant Facility to provide Haiti US$200 million per year for a period of 10 years (2011-2020), subject to annual approval by the Governors. The evaluation confirms that the financial mandates included in IDB-9 have been fulfilled. The Bank wrote off Haiti's debt and transferred resources to the Grant Facility to approve grants to the country over the amount previously established, for US$231.6 million in 2010. In 2011 and 2012, the Bank transferred US$200 million per year in Ordinary Capital resources to the Grant Facility. The Bank financed a program for an amount that exceeded the transfers made, totaling US$231.0 million in 2011 and US$228.0 million in 2012. As regards the Bank's role in catalyzing resources from other donors, there were intense efforts, and the Bank leveraged US$136 million in the period 2010-2012. That figure, however, is somewhat lower than for the period preceding the earthquake and the annual amounts received have fallen. Coordination of international donors has proven inadequate, given the challenges facing the country and the management and execution capacity of the Haitian government. In this context, the Bank's sector coordination work in some key sectors is both recognized and valued. The intervention strategy adopted by the Bank emphasized long-term efforts in the sectors where it had been operating, rather than reconstruction, and had very ambitious targets given the limited management capacities of the Government of Haiti. Execution problems, such as poor designs and preinvestment studies, combined with low execution and supervision capacity in executing units, limited the results of these programs. New programs for development in the northern hub, along with institutional support at the sectoral level, involve risks that need to be addressed in a timely manner to ensure results in the long term. Meanwhile, the urgent need for approval and disbursement of US$200 million each year for 10 years does open up new opportunities for establishing a long-term country strategy, but is hindered by the slow, complex process of institution building. The result is pressure on specialists from the Bank and in the country, and this does not necessarily lead to disbursements or to effective efforts to overcome the problems of Haitian society. Haiti remains a major challenge for the IDB, and international coordination is vital if progress is to be made in overcoming the country¿s urgent problems of poverty and low economic growth. In this regard, OVE believes that the effectiveness of the Bank's actions in Haiti will depend on assessing the constraints associated with country's fragile condition, redefining sector targets and outcomes in line with the context, and paying special attention to reconstruction efforts. Lastly, harmonizing approvals and disbursements with the actual implementation conditions in the executing agencies involved, and respecting the time-frames needed to provide assistance in institution building within the country through a segmented allocation strategy, would make it possible to ensure the Bank's sustained, long-term support.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Slow Vital Capacity' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography